Martyn Thomas1*, MD; Christoph A. Nienaber2, MD; Hüseyin Ince2, MD, PhD; Andrejs Erglis3, MD, PhD; Vladan Vukcevic4, MD; Ulrich Schäfer5, MD; Rui Cruz Ferreira6, MD; Stefan Hardt7, MD; Stefan Verheye8, MD, PhD; Vasco Gama Ribeiro9, MD; Lissa Sugeng10, MD, MPH; Corrado Tamburino11, MD
1. St. Thomas’ Hospital, London, United Kingdom; 2. University of Rostock, Rostock, Germany; 3. Pauls Stradins Clinical University Hospital, Riga, Latvia; 4. Clinical Center of Serbia, Belgrade, Serbia; 5. Asklepios Klinik St. Georg, Hamburg, Germany; 6.
Aims: This prospective, non-randomised, observational study conducted in Europe was designed in order to assess the long-term safety and efficacy of the Parachute device in ischaemic hear